Left ventricular (LV) function was normal or moderately impaired
(mean LV ejection fraction 61 +/- 13%). All patients underwent sequential TWA testing using atrial and ventricular pacing.
Results: During atrial pacing requiring physiologic conduction to the ventricles, 21% of TWA tests were positive, 43% negative, and 36% indeterminate. When using right ventricular (RV) pacing in the same patients, 19% of tests were positive, 40% negative, and 41% indeterminate. When positive and indeterminate tests were grouped as nonnegative, the concordance between atrial and ventricular pacing was 62% (kappa = 0.22). After a mean follow-up of 5.9 +/- 1.9 years, 18 (29%) patients had died. Improved survival was predicted by a negative TWA test using atrial pacing (P = 0.028), but not with ventricular pacing (P = 0.722).
GSI-IX cost In patients with dual-chamber pacemakers, there is a low concordance of TWA test results between atrial pacing with intrinsic conduction to the ventricles and apical RV pacing via pacemaker electrode. However, TWA during atrial pacing clearly exerts long-term prognostic relevance in a patient group with preserved LV function and structural heart disease. (PACE 2011; 34:1054-1062)”
“We present the study of the magnetic properties of well-characterized epitaxial half metallic La0.7Sr0.3MnO3 films grown onto vicinal SrTiO3(001) substrates with different miscut angles. Room temperature high resolution PP2 molecular weight vectorial Kerr magnetometry measurements have been performed at different applied magnetic field directions in the whole angular range. The films present a substrate-induced uniaxial (twofold) magnetic anisotropy originated from in-plane
-oriented elongated structures, whereas the strength of this anisotropy increases with the miscut angle of the substrate surfaces. Our results demonstrate that we can artificially control the magnetic anisotropy of epitaxial films, up to 120 nm thick, by exploiting the substrate-induced anisotropy. We also determine in this case the minimum vicinal angle required to get well-defined BTSA1 Apoptosis inhibitor uniaxial magnetic anisotropy. (C) 2011 American Institute of Physics. [doi: 10.1063/1.3560893]“
“Background: Implantable cardioverter defibrillators (ICDs) have been used in the treatment of either sustained ventricular tachycardia or ventricular fibrillation in patients with Chagas’ cardiomyopathy. This study aimed at determining mortality rate and risk factors of all-cause 1-year mortality in primary and secondary ICD patients with Chagas’ cardiomyopathy.
Methods: One hundred and forty-eight Chagas’ patients with ICDs were included from the Medtronic ICD Registry Latin America. All patients were followed for 1 year.
Results: At implant, mean age was 60.1 +/- 9.4 years and 72.9% were male. Mean left ventricular ejection fraction (LVEF) was 40.1 +/- 11%. Mean follow-up was 12 +/- 7 months. During the follow-up, 15 patients died (10.2%).